Limba
|
Lirametostat (CPI-1205) is an orally available selective inhibitor of the histone lysine methyltransferase EZH2with IC50 values of 2 nM and 52 nM for EZH2 and EZH1 respectively. It has potential antineoplastic activity.
Price | 10.848,00 RON (preturile sunt fara TVA) |
---|---|
Description |
Lirametostat (CPI-1205) is an orally available selective inhibitor of the histone lysine methyltransferase EZH2with IC50 values of 2 nM and 52 nM for EZH2 and EZH1 respectively. It has potential antineoplastic activity. |